BCG vaccine of 2004 the vaccine is given to about 100 million children per year globally. The main use of BCG is for vaccination against tuberculosis. BCG vaccine can be administered after birth intradermally. BCG vaccination can cause a false positive Mantoux test, although a very high-grade reading is usually due to active disease. The most controversial aspect of BCG is the variable efficacy found in different clinical trials, which appears to depend on geography. Trials conducted in the UK have consistently shown a protective effect of 60 to 80%, but those conducted elsewhere have shown no protective effect, and efficacy appears
Inoculation theory (Banas & Rains, 2010, p. 285). Recent research has studied the presence and function of word-of-mouth communication, or post-inoculation talk (see Compton & Pfau, 2009), following exposure to inoculation messages (e.g., Ivanov et al., 2015). Delay is the next element that is necessary in the inoculation process. There has been much debate on whether there is a certain amount of time necessary between inoculation and further attacks on a persons' attitude that will be most effective in strengthening that person's attitude. McGuire (1961) suggested that delay was necessary strengthening a person's attitude and since then many scholars have found evidence